touchPODCAST

Managing disease progression: Considerations for treatment selection and sequencing

touchMDT for touchONCOLOGY

Listen to leading specialists from the MDT discuss the role of monitoring in identifying disease progression, and review the current and emerging treatment options for a patient with a pancreatic NET.

The multidisciplinary team and patient

• Medical oncologist: Dr Diane Reidy-Lagunes, USA
• Nuclear medicine physician: Dr Thomas Hope, USA
• Endocrinologist: Prof. Dr med. Marianne Pavel, Germany
• Nurse specialist: Catherine Bouvier Ellis, UK

This touchPODCAST is for HCPs only. Funding for this touchPODCAST is from an unrestricted independent medical educational grant from Advanced Accelerator Applications. This activity is jointly provided by USF Health and touchIME.

 

For further information visit our website: https://touchoncologyime.org/mdt-management-nets/

Supporting treatment adherence: What strategies are needed for safety management?

touchMDT for touchONCOLOGY

Listen to leading specialists from the MDT discuss the side effects associated with treatment in a patient with liver-dominant disease and the importance of addressing patient needs in ensuring adherence to treatment.  

The multidisciplinary team and patient

• Medical oncologist: Dr Diane Reidy-Lagunes, USA
• Nuclear medicine physician: Dr Thomas Hope, USA
• Nurse specialist: Catherine Bouvier Ellis, UK

This touchPODCAST is for HCPs only. Funding for this touchPODCAST is from an unrestricted independent medical educational grant from Advanced Accelerator Applications. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncologyime.org/mdt-management-nets/

Mapping an individualized treatment plan: What role does the MDT play?

Mapping an individualized treatment plan: What role does the MDT play?

Listen to leading specialists from the MDT discuss the importance of a coordinated approach to clinical decision making in a patient with a lung NET.

The multidisciplinary team 

• Medical oncologist: Dr Diane Reidy-Lagunes, USA
• Nuclear medicine physician: Dr Thomas Hope, USA
• Endocrinologist: Prof. Dr med. Marianne Pavel, Germany

This touchPODCAST is for HCPs only. Funding for this touchPODCAST is from an unrestricted independent medical educational grant from Advanced Accelerator Applications. This medical education is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncologyime.org/mdt-management-nets/ 

Achieving a timely and accurate diagnosis: How can multidisciplinary input address current challenges?

touchMDT for touchONCOLOGY

 

Listen to leading specialists from the MDT discuss the diagnostic workup and challenges associated with diagnosing rare and unusual NETs.

 

The multidisciplinary team

• Medical oncologist: Dr Diane Reidy-Lagunes, USA
• Nuclear medicine physician: Dr Thomas Hope, USA
• Endocrinologist: Prof. Dr med. Marianne Pavel, Germany

 

This touchPODCAST is for HCPs only. Funding for this touchPODCAST is from an unrestricted independent medical educational grant from Advanced Accelerator Applications. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncologyime.org/mdt-management-nets/

 

Managing disease progression: Considerations for treatment selection and sequencing

touchMDT for touchENDOCRINOLOGY

Listen to leading specialists from the MDT discuss the role of monitoring in identifying disease progression, and review the current and emerging treatment options for a patient with a pancreatic NET.

 

The multidisciplinary team and patient

• Medical oncologist: Dr Diane Reidy-Lagunes, USA
• Nuclear medicine physician: Dr Thomas Hope, USA
• Endocrinologist: Prof. Dr med. Marianne Pavel, Germany
• Nurse specialist: Catherine Bouvier Ellis, UK

 

This touchPODCAST is for HCPs only. Funding for this touchPODCAST is from an unrestricted independent medical educational grant from Advanced Accelerator Applications. This activity is jointly provided by USF Health and touchIME.

 

For further information visit our website: https://touchendocrinologyime.org/mdt-management-nets/

Supporting treatment adherence: What strategies are needed for safety management?

touchMDT for touchENDOCRINOLOGY

 

Listen to leading specialists from the MDT discuss the side effects associated with treatment in a patient with liver-dominant disease and the importance of addressing patient needs in ensuring adherence to treatment.  

 

The multidisciplinary team and patient

• Medical oncologist: Dr Diane Reidy-Lagunes, USA
• Nuclear medicine physician: Dr Thomas Hope, USA
• Nurse specialist: Catherine Bouvier Ellis, UK

 

This touchPODCAST is for HCPs only. Funding for this touchPODCAST is from an unrestricted independent medical educational grant from Advanced Accelerator Applications. This activity is jointly provided by USF Health and touchIME.

 

For further information visit our website: https://touchendocrinologyime.org/mdt-management-nets/

Mapping an individualized treatment plan: What role does the MDT play?

touchMDT for touchENDOCRINOLOGY

 

Listen to leading specialists from the MDT discuss the importance of a coordinated approach to clinical decision making in a patient with a lung NET.

 

The multidisciplinary team 

• Medical oncologist: Dr Diane Reidy-Lagunes, USA
• Nuclear medicine physician: Dr Thomas Hope, USA
• Endocrinologist: Prof. Dr med. Marianne Pavel, Germany

 

This touchPODCAST is for HCPs only. Funding for this touchPODCAST is from an unrestricted independent medical educational grant from Advanced Accelerator Applications. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchendocrinologyime.org/mdt-management-nets/ 

 

Achieving a timely and accurate diagnosis: How can multidisciplinary input address current challenges?

touchMDT for touchENDOCRINOLOGY

 

Listen to leading specialists from the MDT discuss the diagnostic workup and challenges associated with diagnosing rare and unusual NETs.

 

The multidisciplinary team

• Medical oncologist: Dr Diane Reidy-Lagunes, USA
• Nuclear medicine physician: Dr Thomas Hope, USA
• Endocrinologist: Prof. Dr med. Marianne Pavel, Germany

 

This touchPODCAST is for HCPs only. Funding for this touchPODCAST is from an unrestricted independent medical educational grant from Advanced Accelerator Applications.  This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchendocrinologyime.org/mdt-management-nets/

Understanding alopecia areata: Current perspectives and emerging therapies for a complex disease

touchIN CONVERSATION for touchIMMUNOLOGY

Listen to two expert dermatologists, Dr Maryanne Senna and Dr Anna Waśkiel-Burnat, discuss current understanding of alopecia areata, including the burden associated with the disease, its pathophysiology, and the potential role of emerging therapies in improving patient outcomes. 

The discussion is stimulated by questions posed by healthcare professionals involved in the management of alopecia areata. 

This touchPODCAST is for HCPs only. 

This activity is funded by an unrestricted independent medical education grant from Eli Lilly. This activity is jointly provided by USF Health and touchIME.

For further information visit our website:
www.touchimmunology.com 

Advancing the management of MDS and AML: Novel immune-based approaches

touchEXPERT OPINIONS for touchONCOLOGY 

Listen to three experts describe the role of immune dysregulation in myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML), and summarize the rationale and available data for emerging immune-based therapeutic strategies. In a short panel discussion, they consider the possible impact these therapies may have on future clinical practice.

The experts

• Prof. Dr. med. Uwe Platzbecker — University Hospital Leipzig, Leipzig, Germany
• Prof. Agnieszka Wierzbowska — Medical University of Łódź, Copernicus Memorial Hospital, Łódź, Poland
• Prof. Valeria Santini — University of Florence, Florence, Italy

This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Novartis. This activity is provided by touchIME.

For further information visit our website: touchONCOLOGY